Position in VTRS
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$1,142,835
+$261,649 QoQ
Shares Held
71,967
+1.7% QoQ
Ownership
0.006%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#304
of 1,022 holders
Holding Since
Dec 2020
22 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in VTRS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026QUADRANT CAPITAL GROUP LLC holds $12,861,475 across 15 Drug Manufacturers - Specialty & Generic names. VTRS ranks #5 (8.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | UTHR |
UNITED THERAPEUTICS Corp
|
4,959 | $2,686,934 | |
| 2 | RDY |
Dr Reddys Laboratories Ltd
|
111,861 | $1,620,865 | |
| 3 | NBIX |
Neurocrine Biosciences Inc
|
8,171 | $1,377,140 | |
| 4 | TAK |
Takeda Pharmaceutical Co Ltd
|
81,606 | $1,308,144 | |
| 5 | VTRS |
Viatris Inc
This page
|
71,967 | $1,142,835 | |
| 6 | LNTH |
Lantheus Holdings, Inc.
|
7,926 | $879,310 | |
| 7 | TEVA |
Teva Pharmaceutical Industries Ltd
|
23,551 | $797,907 | |
| 8 | ALKS |
Alkermes plc.
|
13,278 | $695,767 |
All Filings in VTRS
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,142,835 | 71,967 | Shares | Sole | 2026-08-14 | |
| 2025-12-31 | $881,186 | 70,778 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $697,979 | 70,503 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $627,993 | 70,324 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $11,523 | 1,323 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $22,123 | 1,777 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $21,617 | 1,862 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $20,133 | 1,894 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $22,614 | 1,894 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $19,992 | 1,846 | Shares | Sole | 2024-02-08 | |
| 2023-09-30 | $31,561 | 3,201 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $28,622 | 2,868 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $22,126 | 2,300 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $24,051 | 2,161 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $26,769 | 3,142 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $37,283 | 3,561 | Shares | Sole | 2022-08-09 | |
| 2022-03-31 | $39,918 | 3,669 | Shares | Sole | 2022-05-06 | |
| 2021-12-31 | $51,089 | 3,776 | Shares | Sole | 2022-02-01 | |
| 2021-09-30 | $43,170 | 3,186 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $44,241 | 3,096 | Shares | Sole | 2021-08-09 | |
| 2021-03-31 | $69,640 | 4,985 | Shares | Sole | 2021-05-12 | |
| 2020-12-31 | $101,345 | 5,408 | Shares | Sole | 2021-02-16 | |
| No filing history on record for this holder in this stock. | ||||||